Company attributes
Other attributes
Hey Jane provides telehealth abortion services and medication to pregnant people in select states. The company was founded in 2019 by Kiki Freedman, Gaby Izarra, and Kate Shaw.
Hey Jane mails the FDA-approved abortion drug mifepristone to eligible patients and provides personal connection and support from a clinical care team member throughout the abortion care process, which patients can complete on their own time. Patients must be at least eighteen years old, medically eligible for a medication abortion, and up to ten weeks pregnant. Communications between doctors and patients are made through Spruce Health, a HIPAA-compliant mobile app. To determine eligibility, patients fill out an intake form on Hey Jane's website. They are connected to a medical provider and, if approved, mailed the medications and a thorough guide detailing the procedure. Hey Jane partners with Honeybee Health to provide medication. The procedure costs $249. Hey Jane does not accept insurance, but patients in need are able to apply for financial assistance from abortion funds. Hey Jane provides patients access to a peer-to-peer support forum called The Lounge, where pregnancy and abortion experiences can be discussed.
As of June 2022, Hey Jane provides treatment to patients residing in the states of New York, California, Washington, Illinois, Colorado, and New Mexico. CEO and founder Kiki Freedman said Hey Jane hopes to eventually provide services to all fifty states.
The day after the leak of the Supreme Court's abortion decision draft, Hey Jane's daily site traffic was quintuple its normal volume. Its open text line saw a forty percent messaging increase in the following two weeks. By the end of June 2022, Hey Jane's daily patient numbers were twenty-five times higher than they were fifteen months before.